Futura Surgicare’s Strategic Entry into the US Market
We are excited to share a major milestone at Futura Surgicare Pvt. Ltd. — our official entry into the United States healthcare market through a strategic partnership with Novo Integrated Sciences.
This collaboration is a significant step forward in our mission to bring high-quality, innovative medical solutions to patients across the globe. The US market, with its rigorous standards and regulatory framework, represents both a challenge and an opportunity. Navigating FDA approvals requires specialized knowledge and experience — which is why we’ve joined forces with Novo Integrated Sciences.
With Novo’s expertise in regulatory affairs, we are confident in accelerating the approval process and ensuring full compliance with US healthcare regulations. This partnership empowers us to introduce our advanced range of surgical sutures and medical devices to American healthcare professionals and institutions.
At Futura Surgicare, everything we do is rooted in excellence, innovation, and patient care. This move reflects our ongoing commitment to improving global health outcomes by delivering reliable and effective medical products.
As we embark on this exciting journey, we look forward to sharing updates and milestones along the way. Stay tuned as we bring our proven solutions to new markets — shaping the future of healthcare, one step at a time.
